Get Live Data

The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Scancell Holdings Share Price
  4. Scancell Holdings Share Regulatory News
  5. Change of Registered Office

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Scancell Holdings Information

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Registered Office

29 Feb 2012 15:49

RNS Number : 4111Y
Scancell Holdings Plc
29 February 2012
 



29 February 2012

 

 

Scancell Holdings Plc

('Scancell Holdings' or the 'Company')

 

Change of registered office

 

Scancell Holdings Plc, (AIM: SCLP), announces that the Company's registered office address has changed to 2 More London Riverside, London, SE1 2AP with immediate effect.

Enquiries

Scancell Holdings Plc

Dr Richard Goodfellow / Professor Lindy Durrant

+ 44 (0)20 7653 9850*

 

 

Newgate Threadneedle (Financial PR)

Guy McDougall/ Heather Armstrong

+ 44 (0)20 7653 9850

 

 

Zeus Capital - Nominated Adviser/Joint Broker

Ross Andrews/Tom Rowley

+ 44 (0)161 831 1512

 

 

XCAP - Joint Broker

Jon Belliss/ Adrian Kirk

+44 (0)207 101 7070

 

*calls to this number will reach Newgate Threadneedle, at Scancell's instruction.

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CROTLMATMBITBFT
123456789
Date   Source Headline
12th Aug 20147:00 amRNSSynergy of SCIB1 with checkpoint inhibitors
19th Jun 20147:00 amRNSDirector/PDMR Shareholding
6th Jun 20147:00 amRNSDNA ImmunoBody Patent Granted in United States
2nd Jun 20147:00 amRNSUpdate on Phase 1/2 trial of SCIB1 in melanoma
15th May 20147:30 amRNSPresents latest SCIB1 data at ASCO
9th May 20148:30 amRNSDirectorate Change
1st May 20147:00 amRNSDr Sally Adams to Join as Development Director
4th Apr 20147:00 amRNSScancell to present SCIB1 at AACR
21st Mar 20147:00 amRNS8mg Higher Dose SCIB1 Study On Track
18th Feb 20147:00 amRNSPublication of Moditope Patent
11th Feb 20147:00 amRNSSCIB1 Granted FDA Orphan Drug Status
10th Feb 20144:43 pmRNSHolding(s) in Company
6th Jan 20147:00 amRNSNottingham Technology Grant
16th Dec 20137:00 amRNSNottingham Trent University Cancer Protein Study
12th Dec 20137:00 amRNSDNA ImmunoBody Patent Granted in Japan
11th Dec 20137:00 amRNSDirector/PDMR Shareholding
9th Dec 20137:00 amRNSHalf Yearly Report
9th Dec 20137:00 amRNSNew data for SCIB1 in metastatic melanoma
18th Nov 20137:00 amRNSRe Agreement with Ichor
1st Nov 20134:56 pmRNSAGM Statement
22nd Oct 20138:00 amRNSDirector/PDMR Shareholding
14th Oct 201310:10 amRNSHolding(s) in Company
8th Oct 20132:54 pmRNSNotice of AGM
1st Oct 20137:00 amRNSInvestor Update
24th Sep 20137:00 amRNSInvestor Update Agenda
10th Sep 20133:06 pmRNSInvestor Day
3rd Sep 20137:00 amRNSDNA ImmunoBody Patent Granted in first market
20th Aug 20137:00 amRNSInclusion on Frankfurt Stock Exchange
12th Aug 20135:16 pmRNSDirector/PDMR Shareholding
8th Aug 20133:15 pmRNSHolding(s) in Company
5th Aug 20132:17 pmRNSHolding(s) in Company
1st Aug 201311:39 amRNSResult of General Meeting
26th Jul 20137:00 amRNSResult of Open Offer
23rd Jul 20137:00 amRNSDirector/PDMR Shareholding
19th Jul 20134:40 pmRNSSecond Price Monitoring Extn
19th Jul 20134:35 pmRNSPrice Monitoring Extension
12th Jul 20137:00 amRNSResearch Update
10th Jul 201310:55 amRNSAnnual Financial Report
9th Jul 20137:00 amRNSProposed Firm Placing and Open Offer
9th Jul 20137:00 amRNSFinal Results
9th Apr 20137:00 amRNSAppointment of Non-Executive Director
14th Mar 20137:00 amRNSRe: The Journal of Clinical Investigation Paper
27th Feb 20132:00 pmRNSDirectorate Change
6th Feb 20137:00 amRNSImmunoBody patent approved for grant in Japan
31st Jan 20137:00 amRNSHalf Yearly Report
29th Jan 20137:00 amRNSUpdate on patient recruitment in clinical trial
12th Dec 20127:00 amRNSDirectorate Change
12th Dec 20127:00 amRNSSCIB1 Trial-Higher Dose Allowed in Phase 1/2 Trial
6th Dec 20127:00 amRNSUpdate on SCIB1 Phase 1/2 clinical trial
3rd Dec 20129:30 amRNSHolding(s) in Company
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.